Risk reducing salpingo-oophorectomy (RRSO)

3 trials

Sponsors

Mie university faculty of Medicine, Nagoya university faculty of Medicine, Kyoto University

Conditions

BRCA1/2 mutant carriersHereditary Breast and Ovarian CancerPatients with mutations in BRCA1/2, BRIP, RAD51C and RAD51D genes

Unknown Phase

Risk-Reducing salpingo-oopholectomy in BRCA1/2 mutant carriers

RecruitingJPRN-UMIN000026299

Mie university faculty of MedicineBRCA1/2 mutant carriers

Start: 2017-03-20Target: 5Updated: 2026-06-29

Risk reducing salpingo-oophorectomy RRSO in BRCA1/2 mutation carriers.

Active, not recruitingJPRN-UMIN000027999

Nagoya university faculty of MedicineHereditary Breast and Ovarian Cancer

Start: 2017-09-01Target: 8Updated: 2026-06-29

A feasibility study of Risk-Reducing Salpingo-Oophorectomy based on hereditary breast and ovarian cancer syndrome -associated gene mutations

RecruitingJPRN-UMIN000044616

Kyoto UniversityPatients with mutations in BRCA1/2, BRIP, RAD51C and RAD51D genes

Start: 2021-01-12Target: 50Updated: 2026-06-29